We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical and Laboratory Characteristics of Sickle Cell Anemia Patients Admitted With Fever

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00736060
Recruitment Status : Completed
First Posted : August 15, 2008
Last Update Posted : August 26, 2011
Sponsor:
Information provided by (Responsible Party):
Dr Koren Ariel, HaEmek Medical Center, Israel

Tracking Information
First Submitted Date August 14, 2008
First Posted Date August 15, 2008
Last Update Posted Date August 26, 2011
Study Start Date May 2008
Primary Completion Date Not Provided
Current Primary Outcome Measures Not Provided
Original Primary Outcome Measures Not Provided
Change History
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Clinical and Laboratory Characteristics of Sickle Cell Anemia Patients Admitted With Fever
Official Title Study the Clinical and Laboratory Characteristics and the Outcome of Sickle Cell Anemia Patients Admitted to the Pediatric Ward Because of Fever as the Presenting Symptom
Brief Summary This study will summarized the clinical and laboratory data and the outcome of all the patients suffering from Sickle Cell Anemia (Including Sickle cell thalassemia) admitted to the pediatric ward.
Detailed Description

The actual protocol for SCA patients admitted with fever is to obtain blood cultures and start empiric antibiotic treatment.

The study cohort included 60 SCA patients actually treated in the Pediatric Hematology Unit.
Study Type Observational
Study Design Time Perspective: Retrospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Probability Sample
Study Population 60 patients treated at the Pediatric Hematology Unit in the Ha'Emek Medical Center suffering from sickle cell anemia or sickle cell thalassemia admitted with fever as the presenting symptom.
Condition
  • Sickle Cell Anemia
  • Sickle Cell Thalassemia
Intervention Other: Observational
Summary of clinical and laboratory data
Study Groups/Cohorts
  • 1
    Sickle cell anemia
    Intervention: Other: Observational
  • 2
    Sickle cell thalassemia
    Intervention: Other: Observational
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Completed
Estimated Enrollment
 (submitted: August 14, 2008)		 60
Original Estimated Enrollment Same as current
Actual Study Completion Date November 2008
Primary Completion Date Not Provided
Eligibility Criteria

Inclusion Criteria: All patients admitted with fever as the only presenting symptom.

Exclusion Criteria: Patients admitted with another causes related or unrelated to sickle cell disease and have also fever.
Sex/Gender
Sexes Eligible for Study: All
Ages Child, Adult, Older Adult
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries Israel
Removed Location Countries  
 
Administrative Information
NCT Number NCT00736060
Other Study ID Numbers 0027-08-EMC
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Current Responsible Party Dr Koren Ariel, HaEmek Medical Center, Israel
Original Responsible Party Dr Koren Ariel - Pediatric Hematology Unit, Ha'Emek Medical Center - Afula - Israel
Current Study Sponsor HaEmek Medical Center, Israel
Original Study Sponsor Same as current
Collaborators Not Provided
Investigators
Principal Investigator: Carina Levin, MD Pediatric Hematology Unit - Ha'Emek Medical Center - Afula - 18101 - Israel
Principal Investigator: Ilena Arshinov, MD Pediatric Dpt B - Ha'Emek Medical Center - Afula - Israel
PRS Account HaEmek Medical Center, Israel
Verification Date August 2011